Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | CONQUER: galcanezumab in treatment-resistant migraine

Stewart Tepper, MD, Professor of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, discusses the results of the CONQUER study (NCT03559257), which evaluated the safety and efficacy of galcanezumab in patients with treatment-resistant episodic or chronic migraine. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).